Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 2B clinical study titled ‘A PHASE 2B, ...
Despite being a first-line treatment for CHE, nearly 40% of patients treated with TCS had inadequate treatment response or contraindications to TCS.
Parade on MSN
Ulta's 'Life-Changing' Skincare Product Has Shoppers with Eczema Raving: 'Can't Recommend Enough'
Eczema, also known as atopic dermatitis, is a chronic skin condition marked by itchy, inflamed and scaly skin. And if you ...
No difference in the risk for eczema or bronchiolitis were noted at 1 year of age with as needed use of acetaminophen or ibuprofen.
It’s Eczema Awareness Month, and dermatologist Dr Bernard Ho explains why this often misunderstood condition is more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback